The Current Ratio as of November 2024 (TTM) for Fortress Biotech, Inc. (FBIO) is 1.37

According to Fortress Biotech, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.37. This represents a change of 7.78% compared to the average of 1.27 of the last 4 quarters.

Fortress Biotech, Inc. (FBIO) Historical Current Ratio (quarterly & annually)

How has FBIO Current Ratio performed in the past?

The mean historical Current Ratio of Fortress Biotech, Inc. over the last ten years is 4.89. The current 1.37 Current Ratio has changed 2.70% with respect to the historical average. Over the past ten years (40 quarters), FBIO's Current Ratio was at its highest in in the September 2014 quarter at 20.26. The Current Ratio was at its lowest in in the June 2023 quarter at 0.99.

Fortress Biotech, Inc. (FBIO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Fortress Biotech, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Fortress Biotech, Inc. (FBIO) Average Current Ratio

How has FBIO Current Ratio performed in the past?

The current Current Ratio of Fortress Biotech, Inc. (FBIO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Fortress Biotech, Inc. (FBIO) Current Ratio vs. Peers

How is FBIO’s Current Ratio compared to its peers?

Fortress Biotech, Inc.’s Current Ratio is greater than Mustang Bio, Inc. (0.46), less than Achilles Therapeutics plc (8.24), greater than Aptose Biosciences Inc. (0.80), less than Fortress Biotech, Inc. (1.37), greater than Checkpoint Therapeutics, Inc. (0.26), less than Avenue Therapeutics, Inc. (4.30), less than Pieris Pharmaceuticals, Inc. (3.95), less than Aileron Therapeutics, Inc. (4.69), greater than Reviva Pharmaceuticals Holdings, Inc. (0.41), greater than Eyenovia, Inc. (0.43), less than Cognition Therapeutics, Inc. (3.07), greater than TransCode Therapeutics, Inc. (1.25), less than Kodiak Sciences Inc. (10.59), less than XOMA Corporation (8.71), greater than ZIVO Bioscience, Inc. (0.17), less than Lumos Pharma, Inc. (4.23), greater than Reviva Pharmaceuticals Holdings, Inc. (0.41), less than Athira Pharma, Inc. (3.97), less than ACADIA Pharmaceuticals Inc. (2.16), less than Cabaletta Bio, Inc. (11.52),

Build a custom stock screener for Fortress Biotech, Inc. (FBIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fortress Biotech, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Fortress Biotech, Inc. (FBIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Fortress Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.